Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

Conditions

• Non Small Cell Lung Cancer
• Cervical Cancer
• SCCHN
• Pancreatic Cancer
• Esophageal SCC
• Metastatic Castration-resistant Prostate Cancer
• Triple Negative Breast Cancer
• Hormone Receptor-positive Breast Cancer
• Epithelial Ovarian Cancer
• Endometrial Cancer
• Tissue Factor-Expressing Solid Tumors

Interventions

• DRUG: XB002
• DRUG: Nivolumab
• DRUG: Bevacizumab

Sponsor

Exelixis